These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26157138)

  • 1. Myosin light chain phosphorylation to the rescue.
    Granzier HL; de Tombe PP
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9148-9. PubMed ID: 26157138
    [No Abstract]   [Full Text] [Related]  

  • 2. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
    Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gradient of myosin regulatory light-chain phosphorylation across the ventricular wall supports cardiac torsion.
    Davis JS; Hassanzadeh S; Winitsky S; Wen H; Aletras A; Epstein ND
    Cold Spring Harb Symp Quant Biol; 2002; 67():345-52. PubMed ID: 12858559
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation.
    Szczesna D; Ghosh D; Li Q; Gomes AV; Guzman G; Arana C; Zhi G; Stull JT; Potter JD
    J Biol Chem; 2001 Mar; 276(10):7086-92. PubMed ID: 11102452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Too light to be essential? Insights from FHC-related mutations in essential myosin light chains.
    Krüger M
    Cardiovasc Res; 2012 Mar; 93(3):381-2. PubMed ID: 22266750
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations of ventricular essential myosin light chain disturb myosin binding and sarcomeric sorting.
    Lossie J; Ushakov DS; Ferenczi MA; Werner S; Keller S; Haase H; Morano I
    Cardiovasc Res; 2012 Mar; 93(3):390-6. PubMed ID: 22131351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A light, rather than a heavy solution for hard working hearts.
    Luft FC
    J Mol Med (Berl); 1999 Sep; 77(9):631-3. PubMed ID: 10569200
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations.
    Huang W; Szczesna-Cordary D
    J Muscle Res Cell Motil; 2015 Dec; 36(6):433-45. PubMed ID: 26385864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myosin regulatory light chain phosphorylation enhances cardiac β-myosin in vitro motility under load.
    Karabina A; Kazmierczak K; Szczesna-Cordary D; Moore JR
    Arch Biochem Biophys; 2015 Aug; 580():14-21. PubMed ID: 26116789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
    Sorajja P; Elliott PM; McKenna WJ
    Europace; 2000 Jan; 2(1):4-14. PubMed ID: 11225594
    [No Abstract]   [Full Text] [Related]  

  • 11. Phosphorylation of the regulatory light chain of myosin in striated muscle: methodological perspectives.
    Yu H; Chakravorty S; Song W; Ferenczi MA
    Eur Biophys J; 2016 Dec; 45(8):779-805. PubMed ID: 27084718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.
    Kabaeva ZT; Perrot A; Wolter B; Dietz R; Cardim N; Correia JM; Schulte HD; Aldashev AA; Mirrakhimov MM; Osterziel KJ
    Eur J Hum Genet; 2002 Nov; 10(11):741-8. PubMed ID: 12404107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional responses of mammalian thick filaments to alterations in myosin regulatory light chains.
    Levine RJ; Yang Z; Epstein ND; Fananapazir L; Stull JT; Sweeney HL
    J Struct Biol; 1998; 122(1-2):149-61. PubMed ID: 9724616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain.
    Huang W; Kazmierczak K; Zhou Z; Aguiar-Pulido V; Narasimhan G; Szczesna-Cordary D
    Arch Biochem Biophys; 2016 Jul; 601():121-32. PubMed ID: 26906074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertrophic cardiomyopathy].
    Arbustini E; Dal Bello B
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):213-23. PubMed ID: 12497910
    [No Abstract]   [Full Text] [Related]  

  • 16. A Novel Missense Mutation p.Gly162Glu of the Gene MYL2 Involved in Hypertrophic Cardiomyopathy: A Pedigree Analysis of a Proband.
    Renaudin P; Janin A; Millat G; Chevalier P
    Mol Diagn Ther; 2018 Apr; 22(2):219-223. PubMed ID: 29549657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile hypertrophic cardiomyopathy associated with a novel MYL3 mutation.
    Jay A; Chikarmane R; Poulik J; Misra VK
    Cardiology; 2013; 124(4):248-51. PubMed ID: 23594557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cardiomyopathy Mutation in the Myosin Essential Light Chain Alters Actomyosin Structure.
    Guhathakurta P; Prochniewicz E; Roopnarine O; Rohde JA; Thomas DD
    Biophys J; 2017 Jul; 113(1):91-100. PubMed ID: 28700929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the symmetric model for myosin-linked regulation: effect of site-directed mutations in the regulatory light chain on scallop myosin.
    Colegrave M; Patel H; Offer G; Chantler PD
    Biochem J; 2003 Aug; 374(Pt 1):89-96. PubMed ID: 12765546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and functional characterization of an Entamoeba histolytica protein (EhMLCI) with features of a myosin essential light chain.
    Meza I; Díaz-Valencia JD; Franco E; Villegas-Sepúlveda N; Lezama RA; Benítez-King G
    Mol Biochem Parasitol; 2012 Jan; 181(1):17-28. PubMed ID: 21963788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.